Urodilatin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''Urodilatin''' is a [[ | {{Short description|A peptide hormone involved in sodium and water balance}} | ||
{{Use dmy dates|date=October 2023}} | |||
[[File:Urodilatin_-_Compound_Summary_(CID_16133394).svg|thumb|right|Chemical structure of Urodilatin]] | |||
'''Urodilatin''' is a [[peptide hormone]] that plays a significant role in the regulation of [[sodium]] and [[water]] balance in the body. It is a member of the [[natriuretic peptide]] family, which also includes [[atrial natriuretic peptide]] (ANP), [[brain natriuretic peptide]] (BNP), and [[C-type natriuretic peptide]] (CNP). | |||
==Structure and | ==Structure and Synthesis== | ||
Urodilatin is synthesized in the [[kidney]]s, specifically in the distal tubules of the [[nephron]]. It is a 32-amino acid peptide that is structurally similar to ANP, differing only by the presence of four additional amino acids at the N-terminus. The synthesis of urodilatin is stimulated by increased blood volume and pressure, which leads to its release into the [[urine]]. | |||
Urodilatin | ==Function== | ||
Urodilatin functions primarily as a [[natriuretic]] and [[diuretic]] agent. It promotes the excretion of sodium and water by increasing the glomerular filtration rate and inhibiting sodium reabsorption in the distal tubules. This action helps to reduce blood volume and pressure, contributing to the regulation of [[blood pressure]] and [[fluid balance]] in the body. | |||
==Mechanism of Action== | |||
The mechanism of action of urodilatin involves binding to the [[natriuretic peptide receptor]]-A (NPR-A) on the surface of target cells in the kidney. This binding activates the [[cyclic guanosine monophosphate]] (cGMP) pathway, leading to the relaxation of vascular smooth muscle and increased renal blood flow. The result is enhanced sodium and water excretion. | |||
==Clinical Significance== | ==Clinical Significance== | ||
Urodilatin has been studied for its potential therapeutic applications in conditions such as [[congestive heart failure]] and [[hypertension]]. Its ability to promote natriuresis and diuresis makes it a candidate for the treatment of fluid overload states. However, further research is needed to fully understand its clinical benefits and potential side effects. | |||
==Related Pages== | |||
* [[Atrial natriuretic peptide]] | |||
* [[Brain natriuretic peptide]] | |||
* [[C-type natriuretic peptide]] | |||
* [[Natriuretic peptide]] | * [[Natriuretic peptide]] | ||
[[Category:Peptide hormones]] | |||
[[Category:Renal physiology]] | |||
Revision as of 16:13, 9 February 2025
A peptide hormone involved in sodium and water balance
.svg)
Urodilatin is a peptide hormone that plays a significant role in the regulation of sodium and water balance in the body. It is a member of the natriuretic peptide family, which also includes atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP).
Structure and Synthesis
Urodilatin is synthesized in the kidneys, specifically in the distal tubules of the nephron. It is a 32-amino acid peptide that is structurally similar to ANP, differing only by the presence of four additional amino acids at the N-terminus. The synthesis of urodilatin is stimulated by increased blood volume and pressure, which leads to its release into the urine.
Function
Urodilatin functions primarily as a natriuretic and diuretic agent. It promotes the excretion of sodium and water by increasing the glomerular filtration rate and inhibiting sodium reabsorption in the distal tubules. This action helps to reduce blood volume and pressure, contributing to the regulation of blood pressure and fluid balance in the body.
Mechanism of Action
The mechanism of action of urodilatin involves binding to the natriuretic peptide receptor-A (NPR-A) on the surface of target cells in the kidney. This binding activates the cyclic guanosine monophosphate (cGMP) pathway, leading to the relaxation of vascular smooth muscle and increased renal blood flow. The result is enhanced sodium and water excretion.
Clinical Significance
Urodilatin has been studied for its potential therapeutic applications in conditions such as congestive heart failure and hypertension. Its ability to promote natriuresis and diuresis makes it a candidate for the treatment of fluid overload states. However, further research is needed to fully understand its clinical benefits and potential side effects.
